Centanafadine (Simtriyo): a triple monoamine reuptake inhibitor for ADHD

Juqian Han, Chenyao Jiang, Alyssia Antwania Pruitt, Ying Yu, Jianxiong Jiang

Open source

DOI
10.1016/j.tips.2026.08.011
Published
2026-09
Container
Trends in Pharmacological Sciences
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.tips.2026.08.011,
  title = {Centanafadine (Simtriyo): a triple monoamine reuptake inhibitor for ADHD},
  author = {Juqian Han and Chenyao Jiang and Alyssia Antwania Pruitt and Ying Yu and Jianxiong Jiang},
  year = {2026},
  journal = {Trends in Pharmacological Sciences},
  doi = {10.1016/j.tips.2026.08.011},
  url = {https://doi.org/10.1016/j.tips.2026.08.011}
}

RIS

TY  - JOUR
TI  - Centanafadine (Simtriyo): a triple monoamine reuptake inhibitor for ADHD
AU  - Juqian Han
AU  - Chenyao Jiang
AU  - Alyssia Antwania Pruitt
AU  - Ying Yu
AU  - Jianxiong Jiang
PY  - 2026
JO  - Trends in Pharmacological Sciences
DO  - 10.1016/j.tips.2026.08.011
UR  - https://doi.org/10.1016/j.tips.2026.08.011
ER  - 

APA

Han, J., Jiang, C., Pruitt, A. A., Yu, Y., & Jiang, J. (2026). Centanafadine (Simtriyo): a triple monoamine reuptake inhibitor for ADHD. Trends in Pharmacological Sciences. https://doi.org/10.1016/j.tips.2026.08.011

Source records